Statement attributable to:
Susan R. Bailey, MD
President, American Medical Association

“The Biden Administration has wisely withdrawn a pilot waiver that would have threatened the long-term outlook for Medicare beneficiaries. The American Medical Association has long advocated for the need to preserve Medicare patients’ access to drugs in the six protected classes and welcomes this change in the model. This ill-considered waiver would have denied vulnerable patients access to necessary and potentially life-saving medications. They can breathe a sigh of relief knowing that the administration was looking out for them.”

Media Contact:

Jack Deutsch

ph: (202) 789-7442

[email protected]

About the American Medical Association

The American Medical Association is the physicians’ powerful ally in patient care. As the only medical association that convenes 190+ state and specialty medical societies and other critical stakeholders, the AMA represents physicians with a unified voice to all key players in health care.  The AMA leverages its strength by removing the obstacles that interfere with patient care, leading the charge to prevent chronic disease and confront public health crises and, driving the future of medicine to tackle the biggest challenges in health care.

Featured Stories